GCG and cancer: For instance, with the progression of clinical stage, GLP-1 signaling score decreased in most cancers, including ACC, BLCA, BRCA, ESCA, HNSC, KIRC, THCA and PAAD (Figures 5A–H), while the opposite trend was observed in STAD (Figure 5I).